Tower Research Capital (TRC)’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $838 | Sell |
|
|||||
|
2025
Q2 | $5.01K | Sell |
|
|||||
|
2025
Q1 | $6.79K | Buy |
|
|||||
|
2024
Q4 | $4.86K | Buy |
|
|||||
|
2024
Q3 | $3.62K | Sell |
|
|||||
|
2024
Q2 | $11.1K | Buy |
|
|||||
|
2024
Q1 | $7.53K | Buy |
|
|||||
|
2023
Q4 | $2.58K | Sell |
|
|||||
|
2023
Q3 | $7.28K | Sell |
|
|||||
|
2023
Q2 | $10.5K | Buy |
|
|||||
|
2023
Q1 | $7K | Sell |
|
|||||
|
2022
Q4 | $15K | Buy |
|
|||||
|
2022
Q3 | $15K | Sell |
|
|||||
|
2022
Q2 | $36K | Buy |
|
|||||
|
2022
Q1 | $62K | Buy |
|
|||||
|
2021
Q4 | $64K | Buy |
|
|||||
|
2021
Q3 | $18K | Sell |
|
|||||
|
2021
Q2 | $31K | Sell |
|
|||||
|
2021
Q1 | $51K | Buy |
|
|||||
|
2020
Q4 | $18K | Sell |
|
|||||
|
2020
Q3 | $208K | Buy |
|
|||||
|
2020
Q2 | $56K | Buy |
|